Retinal vascular abnormalities in persons with type 1 diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII☆
Section snippets
Study population
The population has been described in detail in previous reports.11, 12, 13 It consisted of a sample selected from 10,135 diabetic patients who received primary care in an 11-county area in southern Wisconsin from 1979 to 1980. The full sample was composed of younger-onset and older-onset persons. These analyses are limited to the group of younger-onset persons, all of whom were taking insulin and had been diagnosed before 30 years of age (n = 1210). There were 996 persons in this group who
Results
The mean age of the diabetic group was 29 years, and the mean duration of diabetes was 15 years. Hypertension and gross proteinuria were each present in 22% of the diabetic cohort. Retinopathy was present in 72% of the cohort, 23% of whom had proliferative retinopathy. Focal retinal arteriolar narrowing was present in 14%, and A/V nicking was present in 8%. The mean CRAE was 217 μm, the mean CRVE was 245 μm, and the mean AVR was 0.88.
Discussion
The data reported herein are unique in describing information regarding the distributions of microvascular disease (generalized and focal retinal arteriolar narrowing, venular dilation, and A/V nicking) and their associations with systemic and ocular factors in a population-based cohort composed of all known patients with type 1 diabetes diagnosed before 30 years of age who were receiving treatment in a defined geographic area during a specified period. Quantifying the retinal arterioles and
Acknowledgements
We are grateful to the 452 Wisconsin physicians and their staff who participated in and supported this study.
References (49)
- et al.
Retinal microvascular abnormalities and incident strokethe Atherosclerosis Risk in Communities Study
Lancet
(2001) - et al.
Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study
Ophthalmology
(1999) - et al.
Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies
J Clin Epidemiol
(1988) - et al.
An alternative method of grading diabetic retinopathy
Ophthalmology
(1986) - et al.
Diabetic retinopathyassessment of severity and progression
Ophthalmology
(1984) - et al.
General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery
Am J Ophthalmol
(1974) - et al.
Mathematic relationships between the width of a retinal artery and the widths of its branches
Am J Ophthalmol
(1974) - et al.
Laser Doppler measurements of the effect of panretinal photocoagulation on retinal blood flow
Ophthalmology
(1982) - et al.
Effect of panretinal photocoagulation on retinal blood flow in proliferative diabetic retinopathy
Ophthalmology
(1986) - et al.
Pathophysiology of hypertensive retinopathy
Ophthalmology
(1982)
Diameters of the retinal vessels in diabetic and normal subjects
Diabetes
Vessel measurements in diabetic fundi
Proc R Soc Med
Oxygenation and vasodilation in relation to diabetic and other proliferative retinopathies
Ophthalmic Surg
Fundus photography of width and intensity profiles of the blood column and the light reflex in retinal vessels
Acta Ophthalmol (Copenh)
Laser Doppler velocimetry study of retinal circulation in diabetes mellitus
Arch Ophthalmol
Retinal vasodilation and hyperglycaemia in diabetic children and adolescents
Acta Ophthalmol Scand
Retinal arteriolar narrowing and risk of coronary heart disease in men and womenthe Atherosclerosis Risk in Communities Study
JAMA
Prevalence of diabetes mellitus in southern Wisconsin
Am J Epidemiol
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
Arch Ophthalmol
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years
Arch Ophthalmol
The hypertensive detection and follow-up program
Prev Med
Cited by (120)
Retinal microvascular function predicts chronic kidney disease in patients with cardiovascular risk factors
2022, AtherosclerosisCitation Excerpt :single timepoint) retinal images to investigate the relationship between a range of retinal microvascular changes and CKD [27,28]. For example, static measurements of retinal arteriolar narrowing and venular dilatation, have been reported in established CKD risk factors, such as hypertension [29] and diabetes [30], with cross-sectional studies further describing a direct association between retinal arteriolar narrowing and CKD [31,32]. Similarly, large population-based studies have described an independent link between retinopathy signs (ie.
Clarifying the effects of diabetes on the cerebral circulation: Implications for stroke recovery and beyond
2021, Brain Research BulletinCitation Excerpt :Diabetic retinopathy involves a complicated pathologic process. The earliest changes leading to diabetic retinopathy include narrowing of the retinal arteries (Ciulla et al., 2002; Klein et al., 2003), which is followed by the shift to retinal hyperperfusion (Ciulla et al., 2002). And the hyperperfusion then leads to vascular basement membrane thickening, loss of arterial tone, formation of microaneurysms and acellular capillary formation which exacerbates retinal ischaemia (Curtis and Gardiner, 2012).
Retinal Vascular Caliber Association with Nonperfusion and Diabetic Retinopathy Severity Depends on Vascular Caliber Measurement Location
2021, Ophthalmology RetinaCitation Excerpt :Previous studies have used CRAE, a summary metric extrapolated from inner arteriole calibers. The CRAE studies have yielded conflicting results, with some reporting decreasing CRAE with increasing DR severity,5,11 and others finding no significant changes.12,25 Furthermore, the results of longitudinal studies also have been inconsistent, with greater baseline CRAE being associated with increased progression rates in some studies, and no such associations found in others.4–6,11
The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons
2020, Kidney InternationalA deep learning system for predicting time to progression of diabetic retinopathy
2024, Nature Medicine
- ☆
Manuscript no. 220874.
Supported by the National Institutes of Health, Bethesda, Maryland (grant no. EY03083-19) and the National Heart, Lung, and Blood Institute, Bethesda, Maryland (grant no. HL59259-03).